Organogenesis Holdings Inc. - 8-K Filing

Organogenesis Holdings reports Q3 2026 net revenue of $45.5 million, a 70% year-over-year decrease, and issues revised full-year revenue guidance. (Items: 2.02 Results of Operations and Financial ConditionOn November 5, 2026, the Company announced via press release its results for the fiscal third qu, 9.01 Financial Statements and Exhibits)

SEC EDGAR ·

Tickers: $ORGO

Read the full article at SEC EDGAR

More Regulatory news